RecruitingNot ApplicableNCT06914349

Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure

Antecolic Versus Retrocolic Gastrojejunostomy Following Pancreaticoduodenectomy: a Prospective Randomised Study


Sponsor

University of Thessaly

Enrollment

76 participants

Start Date

Mar 30, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Aim: This randomized clinical study aims to compare occurrence of DGE in patients undergoing either antecolic or retrocolic gastrojejunostomy following pancreaticoduodenectomy. Methods: Participants of this study will be patients undergoing pylorus preserving pancreaticoduodenectomy at the Surgical Department of the University Hospital of Larissa. Patients will be randomized to undergo either an antecolic or a retrocolic gastrojejunostomy and the occurrence of DGE will then be compared between the two groups. Individuals younger than 18 or older than 75 years old, as well as patients who do not consent to participate in this trial, will be excluded. Expected results: Based on available literature, antecolic gastrojejunostomy may be related with a lower incidence of DGE, without a statistically significant difference between the two methods. We aim to show if one of the two methods of gastrointestinal reconstruction (antecolic versus retrocolic) affects DGE.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • Age over 18 years old
  • Elective pancreaticoduodenectomy
  • Signed consent form

Exclusion Criteria3

  • Age under 18 years old
  • Patients who are participants in other trials that may affect the results of this study
  • Patients who do not consent to participate in the study

Interventions

PROCEDUREAntecolic gastrojejunostomy

Gastrojejunostomy in front of the transverse colon

PROCEDURERetrocolic gastrojejunostomy

Gastrojejunostomy through the transverse mesocolon


Locations(1)

University of Thessaly

Larissa, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06914349


Related Trials